Anti-ICOS (Bristol Myers Squibb)

N/A

Report date: 2022/01/24 09:15:47

Base Information

Drug NameAnti-ICOS (Bristol Myers Squibb)
Drug Alias NameAnti-inducible T-cell costimulator (Bristol Myers Squibb)BMS-986226
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInducible T-cell costimulator agonists
TargetsInducible T-cell costimulator
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb Company
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A